IOVANCE BIOTHERAPEUTICS INC (IOVA) Forecast, Price Target & Analyst Ratings

NASDAQ:IOVA • US4622601007

Current stock price

3.7 USD
-0.31 (-7.73%)
At close:
3.7897 USD
+0.09 (+2.42%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IOVANCE BIOTHERAPEUTICS INC (IOVA).

Forecast Snapshot

Consensus Price Target

Price Target
$9.18
+ 148.11% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.14
Revenue Estimate
85.765M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.82%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.18
Upside
+ 148.11%
From current price of $3.70 to mean target of $9.18, Based on 17 analyst forecasts
Low
$4.04
Median
$9.69
High
$16.80

Price Target Revisions

1 Month
-1.22%
3 Months
7.78%

Price Target Summary

17 Wall Street analysts provided a forecast for the next 12 months for IOVA. The average price target is 9.18 USD. This implies a price increase of 148.11% is expected in the next year compared to the current price of 3.7.
The average price target has been revised upward by 7.78% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IOVA Current Analyst RatingIOVA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

IOVA Historical Analyst RatingsIOVA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
78.82%
IOVA was analyzed by 17 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about IOVA.
In the previous month the buy percentage consensus was at a similar level.
IOVA was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-10Chardan CapitalMaintains Buy -> Buy
2026-03-05UBSMaintains Neutral -> Neutral
2026-03-03CitizensUpgrade Market Perform -> Market Outperform
2026-02-25CitizensUpgrade Market Perform -> Market Outperform
2026-02-25BarclaysMaintains Overweight -> Overweight
2025-12-17BarclaysMaintains Overweight -> Overweight
2025-11-24BarclaysMaintains Overweight -> Overweight
2025-11-06Chardan CapitalMaintains Buy -> Buy
2025-10-29HC Wainwright & Co.Maintains Buy -> Buy
2025-08-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-08Chardan CapitalMaintains Buy -> Buy
2025-08-08Wells FargoMaintains Overweight -> Overweight
2025-07-23Chardan CapitalMaintains Buy -> Buy
2025-05-16UBSDowngrade Buy -> Neutral
2025-05-12MizuhoMaintains Outperform -> Outperform
2025-05-12BarclaysMaintains Overweight -> Overweight
2025-05-12Goldman SachsMaintains Buy -> Buy
2025-05-09Chardan CapitalMaintains Buy -> Buy
2025-05-09JMP SecuritiesDowngrade Market Outperform -> Market Perform
2025-05-09HC Wainwright & Co.Maintains Buy -> Buy
2025-04-17Goldman SachsMaintains Buy -> Buy
2025-04-14BarclaysMaintains Overweight -> Overweight
2025-03-03Chardan CapitalMaintains Buy -> Buy
2025-03-03Truist SecuritiesMaintains Buy -> Buy
2025-03-03Goldman SachsMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q1 / 2026
EPS Estimate
-$0.14
Revenue Estimate
85.765M
Revenue Q2Q
73.88%
EPS Q2Q
61.11%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
1.60%
EPS (1 Month)
0.00%
EPS (3 Months)
11.26%

Next Earnings Summary

IOVA is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.14 USD and the consensus revenue estimate is 85.77M USD.
The next earnings revenue estimate has been revised upward by 1.6% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IOVA revenue by date.IOVA revenue by date.
1.189M164.07M
13,698.99%		263.502M
60.60%		399.33M
51.55%		549.26M
37.55%		745.24M
35.68%		801.96M
7.61%		889.51M
10.92%		734.91M
-17.38%		851.68M
15.89%		984.38M
15.58%
EBITDA
YoY % growth
IOVA ebitda by date.IOVA ebitda by date.
-439.142M
-12.72%		-354.709M
19.23%		-362.274M
-2.13%		-210.599M
41.87%		-118.079M
43.93%		-3.499M
97.04%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
IOVA ebit by date.IOVA ebit by date.
-460.559M
-15.46%		-387.878M
15.78%		-398.213M
-2.66%		-229.755M
42.30%		-122.186M
46.82%		944.928K
100.77%		53.42M
5,553.34%		104.85M
96.27%		28.382M
-72.93%		69.972M
146.54%		127.28M
81.90%
Operating Margin
IOVA operating margin by date.IOVA operating margin by date.
-38,734.99%-236.41%-151.12%-57.54%-22.25%0.13%6.66%11.79%3.86%8.22%12.93%
EPS
YoY % growth
IOVA eps by date.IOVA eps by date.
-1.88
24.19%		-1.30
30.85%		-1.12
13.85%		-0.50
55.58%		-0.22
55.49%		0.03
114.59%		0.23
615.82%		0.57
147.02%		0.41
-28.57%		0.410.41

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.14
61.11%		-0.13
61.48%		-0.12
53.18%		-0.12
32.32%		-0.09
35.15%		-0.07
43.83%		-0.04
69.93%		-0.01
94.56%
Revenue
Q2Q % growth		85.765M
73.88%		95.295M
58.95%		103.84M
53.94%		111.8M
28.84%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-53.402M
52.75%		-50.102M
48.09%		-46.543M
26.99%		-46.813M
-24.76%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-67.387M
44.41%		-61.441M
46.00%		-55.733M
37.91%		-49.265M
32.94%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IOVA Yearly Revenue VS EstimatesIOVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
IOVA Yearly EPS VS EstimatesIOVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -1 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
26.59%
EPS Next 5 Year
20.21%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
41.58%
Revenue Next 5 Year
27.64%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
25.81%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IOVANCE BIOTHERAPEUTICS INC / IOVA Forecast FAQ

Can you provide the average price target for IOVANCE BIOTHERAPEUTICS INC stock?

17 analysts have analysed IOVA and the average price target is 9.18 USD. This implies a price increase of 148.11% is expected in the next year compared to the current price of 3.7.

What is the next earnings date for IOVA stock?

IOVANCE BIOTHERAPEUTICS INC (IOVA) will report earnings on 2026-05-07.

What are the consensus estimates for IOVA stock next earnings?

The consensus EPS estimate for the next earnings of IOVANCE BIOTHERAPEUTICS INC (IOVA) is -0.14 USD and the consensus revenue estimate is 85.77M USD.

What is the expected long term growth rate for IOVA stock?

The expected long term growth rate for IOVANCE BIOTHERAPEUTICS INC (IOVA) is 41.58%.